Innovative researcher Mitchell Halperin advanced the understanding of kidney physiology

Considered a ‘star teacher,’ he focused on research and wrote or co-authored over 350 medical journal articles, 59 book ...

Baxdrostat New Drug Application accepted under FDA Priority Review in the US for patients with hard-to-control hypertension

AstraZeneca’s New Drug Application (NDA) for baxdrostat has been accepted for Priority Review by the US Food and Drug Administration (FDA) in the US for the treatment of adult patients with ...